Heather Raines

This profile gathers the share dealings of Heather Raines in Provectus Biopharmaceuticals, Inc. Over a trading history stretching from 25 March 2019 to 10 November 2020, the count stands at 2 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The record was last updated on 12 November 2020 with a share grant in Provectus Biopharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.